GBT
Global Blood Therapeutics, Inc.
Delisted
GBT was delisted on the 4th of October, 2022.
93 hedge funds and large institutions have $389M invested in Global Blood Therapeutics, Inc. in 2016 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 48 increasing their positions, 11 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
42% more call options, than puts
Call options by funds: $2.21M | Put options by funds: $1.55M
24% more funds holding
Funds holding: 75 → 93 (+18)
Holders
93
Holding in Top 10
3
Calls
$2.21M
Puts
$1.55M
Top Buyers
| 1 | +$19.9M | |
| 2 | +$16.4M | |
| 3 | +$15.9M | |
| 4 |
PA
Perceptive Advisors
New York
|
+$15.1M |
| 5 |
ACA
Avoro Capital Advisors
New York
|
+$12.5M |
Top Sellers
| 1 | -$9.52M | |
| 2 | -$1.78M | |
| 3 | -$1.56M | |
| 4 |
DA
DSC Advisors
Chicago,
Illinois
|
-$1.03M |
| 5 |
Goldman Sachs
New York
|
-$1M |